Fil LTD Bio Rad Laboratories, Inc. Transaction History

Fil LTD

  • $103 Billion
  • Q3 2024

A detailed history of Fil LTD transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Fil LTD holds 539 shares of BIO stock, worth $190,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
539
Holding current value
$190,730
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$263.97 - $344.64 $142,279 - $185,760
539 New
539 $180,000
Q2 2021

Aug 13, 2021
SELL
$576.64 - $649.04 $1,153 - $1,298
-2 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$334.87 - $493.06 $11.1 Million - $16.4 Million
-33,205 Reduced 99.99%
2 $1,000
Q1 2020

May 14, 2020
BUY
$320.01 - $409.07 $10.6 Million - $13.6 Million
33,207 New
33,207 $11.6 Million
Q4 2018

Feb 13, 2019
SELL
$220.1 - $309.0 $5.98 Million - $8.4 Million
-27,188 Closed
0 $0
Q3 2018

Nov 09, 2018
SELL
$289.28 - $326.15 $7.86 Million - $8.86 Million
-27,162 Reduced 49.98%
27,188 $8.51 Million
Q2 2018

Aug 10, 2018
SELL
$244.1 - $303.88 $3.56 Million - $4.44 Million
-14,600 Reduced 21.17%
54,350 $15.7 Million
Q1 2018

May 14, 2018
BUY
$233.97 - $274.11 $6.19 Million - $7.26 Million
26,469 Added 62.31%
68,950 $17.2 Million
Q3 2017

Nov 13, 2017
BUY
$212.27 - $242.28 $6.49 Million - $7.4 Million
30,559 Added 256.32%
42,481 $9.44 Million
Q2 2017

Aug 29, 2017
BUY
N/A
11,922
11,922 $2.7 Million

Others Institutions Holding BIO

# of Institutions
455
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.72B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email